November 21, 2026 · Chest · DOI: 10.1016/j.chest.2026.11.014

Real-World Outcomes of Long-Acting Beta-Agonist Add-On Therapy to Inhaled Corticosteroids in Preschool Children with Asthma: A Multicenter Retrospective Study.

Listen to this summary

This retrospective TriNetX study of about 12,100 propensity-matched children aged 6 or younger asked whether adding a long-acting beta-agonist (LABA) to inhaled corticosteroids (ICS) is associated with better or worse outcomes than ICS alone. ICS+LABA was linked to higher hazards of systemic steroid use, bronchodilator use, and pneumonia when indexed at asthma diagnosis, but these excess risks shrank substantially when time was reset to the LABA start date. The authors conclude that the apparent harms largely reflect the uncontrolled asthma that prompted escalation, and that the findings offer real-world support for ICS+LABA in selected preschoolers, pending prospective trials.

Guy Hazan, Shoham Jellinek, Keren Armoni-Domany, Alex Gileles-Hillel

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play